HOUSE-BILL 3037: H.R.3037 - Access to Breast Cancer Diagnosis Act of 2025
AI-Powered Summary
HOUSE-BILL 3037 aims to enhance access to healthcare by prohibiting cost-sharing requirements for diagnostic and supplemental breast examinations under group health plans and individual health insurance. The legislation addresses major themes of healthcare access and equity, particularly concerning breast cancer diagnosis and treatment. Key provisions include the mandate that health plans cannot impose out-of-pocket expenses for these examinations, while still allowing for prior authorization and utilization controls. The bill does not override state laws that may offer greater protections, thus respecting states' rights to enhance healthcare regulations. The effective date for these changes is set for plan years beginning on or after January 1, 2026, allowing time for implementation. Potential impacts include improved access to necessary medical services for individuals, implications for constitutional rights related to healthcare access, and discussions around federal authority versus state rights in regulating health insurance.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill positively impacts individuals by ensuring equitable access to breast cancer diagnostic services, which is crucial for public health and individual rights. It aims to eliminate financial barriers that disproportionately affect women and low-income individuals, thereby promoting health equity.
Key Individual Rights Affected
- Right to health care access
- Equal protection under the law
Constitutional Provisions
- Equal Protection Clause of the Fourteenth Amendment
- Commerce Clause
Potential Constitutional Challenges Or Support
While the bill supports equal access to health care, it may face scrutiny regarding its focus on women's health and whether it adequately addresses the needs of all demographic groups. Additionally, the potential for state law preemption could complicate its implementation and raise federalism concerns.
Summary
HOUSE-BILL 3037 represents a significant advancement in health care access, particularly for women at risk of breast cancer. By eliminating cost-sharing for diagnostic services, it aligns with constitutional principles of equal protection and health equity. However, careful monitoring is necessary to ensure that it does not inadvertently create disparities among different demographic groups.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 3037 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
April 28, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat